Skip to content

Author

M. Quraishi

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Subcutaneous infliximab in inflammatory bowel disease: from pharmacokinetic principles to clinical practice.

INTRODUCTION Subcutaneous infliximab (CT-P13 SC) was developed to address the pronounced peak-to-trough fluctuations of intravenous dosing and the immunogenicity driven by sub-therapeutic troughs. Through a stable steady-state pharmacokinetic profile it meets the international Delphi consensus definition of a biobetter...

M. N. Quraishi, S. Elouali · 0 citations
Review Open access Aug 2026

Targeting the TL1A pathway in inflammatory bowel disease: mechanistic insights and emerging therapeutic pipeline.

This narrative review provides a contemporary appraisal of TL1A-directed therapeutics in inflammatory bowel disease based on electronic searches through May 2026, and discusses therapeutic positioning and timing, the opportunity in acute severe UC, and the unusual standing of IBD as the lead indication for this mechani...

M. N. Quraishi, V. Jairath, B. Al-Bawardy · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.